Basic Information
| LncRNA/CircRNA Name | LINC-ROR |
| Synonyms | LINC-ROR, ROR, lincRNA-RoR |
| Region | GRCh38_18:57054558-57072119 |
| Ensemble | ENSG00000258609 |
| Refseq | NR_048536 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | sarcoma |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | sarcoma tissues |
| Expression Pattern | down-regulated |
| Function Description | Among the various tested cancerous tissue samples, three demonstrated overexpression of LINC-ROR including cervical, ovarian, and esophageal cancers. In contrast, the expression in breast, melanoma, colon, and sarcoma tumors was mainly reduced compared to normal controls |
| Pubmed ID | 26314857 |
| Year | 2016 |
| Title | Altered expression of LINC-ROR in cancer cell lines and tissues. |
External Links
| Links for LINC-ROR | GenBank HGNC NONCODE |
| Links for sarcoma | OMIM COSMIC |